| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Supplement |
1 From the Departments of Biochemistry and Food Chemistry and Pediatrics, University of Turku, Turku, Finland, and Food Science Australia, Melbourne Laboratory, Highett, Australia.
Acid and bile stability and intestinal mucosal adhesion properties are among the criteria used to select probiotic microbes. The quality control of probiotic cultures in foods traditionally has relied solely on tests to ensure that an adequate number of viable bacteria are present in the products throughout their shelf lives. Viability is an important factor, but not the only criterion for quality assurance. To be effective, probiotic strains must retain the functional health characteristics for which they were originally selected. Such characteristics include the ability to survive transit through the stomach and small intestine and to colonize the human gastrointestinal tract. In vitro test protocols can be readily adopted to examine the maintenance of a strain's ability to tolerate acidic conditions, survive and grow in the presence of bile, and metabolize selective substrates. Molecular techniques are also available to examine strain stability. Adhesion characterization may be an important quality-control method for assessing gut barrier effects. Adhesion has been related to shortening the duration of diarrhea, immunogenic effects, competitive exclusion, and other health effects. Adhesion properties should be carefully monitored, including adhesion to intestinal cells (eg, Caco-2) and human intestinal mucus. This article outlines the types of in vitro testing that can be used to ensure quality control of functional probiotic strains.
Key Words: Probiotics • quality control • adhesion • acid stability • viability
This article has been cited by other articles:
|
|
 |
|
  E. Denou, R. D. Pridmore, B. Berger, J.-M. Panoff, F. Arigoni, and H. Brussow Identification of Genes Associated with the Long-Gut-Persistence Phenotype of the Probiotic Lactobacillus johnsonii Strain NCC533 Using a Combination of Genomics and Transcriptome Analysis J. Bacteriol., May 1, 2008; 190(9): 3161 - 3168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Trois, E. M. Cardoso, and E. Miura Use of Probiotics in HIV-infected Children: A Randomized Double-blind Controlled Study J Trop Pediatr, February 1, 2008; 54(1): 19 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Sheehan, R. D. Sleator, C. Hill, and G. F. Fitzgerald Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003 Microbiology, October 1, 2007; 153(10): 3563 - 3571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Isakow, L. E. Morrow, and M. H. Kollef Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations Chest, July 1, 2007; 132(1): 286 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ben Amor, E. E. Vaughan, and W. M. de Vos Advanced Molecular Tools for the Identification of Lactic Acid Bacteria J. Nutr., March 1, 2007; 137(3): 741S - 747S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tao, K. A. Drabik, T. S. Waypa, M. W. Musch, J. C. Alverdy, O. Schneewind, E. B. Chang, and E. O. Petrof Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1018 - C1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Begley, C. Hill, and C. G. M. Gahan Bile salt hydrolase activity in probiotics. Appl. Envir. Microbiol., March 1, 2006; 72(3): 1729 - 1738. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
